Linde plc
NASDAQ:LINChemicals - Specialty
-$0.89 today
- Market cap
- $235.12B
- Beta
- 0.73
- P/E (TTM)
- 33.5
- EPS (TTM)
- $15.35
- Dividend yield
- 1.20%
Volume 1.37M
Average 2.28M
LIN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Linde plcNASDAQ: LIN
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue growth accelerates
Q2 FY2026 cost of revenue of $5.82B rose 11.0% year over year, ahead of the +6.1% change in trailing-twelve-month cost of revenue. Sequentially, it rose 6.4% from the prior quarter. Over 3 fiscal years it compounded at -3.7% a year.
Context
- Cost of revenue amounted to 62.2% of revenue in FY2025, down 1.2 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +11.0% holds above the trailing-twelve-month pace of +6.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 21.15B USD
- Year-over-year change
- +1.1%
- 4-year CAGR
- -1.2%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.15B | +1.1% |
| FY2024 | 2024-12-31 | 20.92B | -1.8% |
| FY2023 | 2023-12-31 | 21.31B | -9.9% |
| FY2022 | 2022-12-31 | 23.65B | +6.7% |
| FY2021 | 2021-12-31 | 22.18B | — |
Cost of Revenue vs competitors
How LIN compares with its peers on the latest reported figures
- LIN's LTM Jun 2026 cost of revenue of $22.14B is the highest of the 2 companies compared; the peer median is $8.89B.
- Its year-over-year change of +6.1% is the lowest of 2, against a peer median of +7.7%.
- Cost of revenue amounts to 62.4% of revenue for LIN, versus a peer median of 68.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $22.14B | +6.1% | -3.7% | 62.4% | |
| LTM Sep 2026 | $8.89B | +7.7% | +0.2% | 68.4% | |
| Peer median (excluding LIN) | $8.89B | +7.7% | +0.2% | 68.4% | |
Competitors are the stored peer set for LIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 30.79B | 33.36B | 32.85B | 33.01B | 33.99B |
| Cost of Revenue | 22.18B | 23.65B | 21.31B | 20.92B | 21.15B |
| Gross Profit | 8.62B | 9.71B | 11.55B | 12.08B | 12.83B |
| Gross Margin | 28.0% | 29.1% | 35.1% | 36.6% | 37.8% |
| Research & Development | 143M | 143M | 146M | 150M | 147M |
| Selling, General & Admin | 3.19B | 3.11B | 3.3B | 3.34B | 3.43B |
| Operating Expenses | 3.33B | 3.25B | 3.44B | 3.49B | 3.58B |
| Depreciation & Amortization | 4.64B | 4.2B | 3.82B | 3.78B | 3.76B |
| EBITDA | 9.92B | 10.66B | 11.92B | 12.38B | 13.02B |
| EBITDA Margin | 32.2% | 32.0% | 36.3% | 37.5% | 38.3% |
| Operating Income | 5.28B | 6.46B | 8.11B | 8.6B | 9.25B |
| Operating Margin | 17.2% | 19.4% | 24.7% | 26.0% | 27.2% |
| Interest Income | 40M | 117M | 197M | 228M | 209M |
| Interest Expense | 159M | 192M | 488M | 572M | 464M |
| Other Income / Expenses | (65M) | (745M) | 50M | 144M | (207M) |
| Income Before Tax | 5.22B | 5.72B | 8.16B | 8.74B | 9.05B |
| Pre-Tax Margin | 16.9% | 17.1% | 24.8% | 26.5% | 26.6% |
| Income Tax Expense | 1.26B | 1.43B | 1.81B | 2B | 1.99B |
| Net Income | 3.83B | 4.15B | 6.2B | 6.57B | 6.9B |
| Net Margin | 12.4% | 12.4% | 18.9% | 19.9% | 20.3% |
| EPS (Basic) | 7.40 | 8.30 | 12.70 | 13.71 | 14.67 |
| EPS (Diluted) | 7.33 | 8.23 | 12.59 | 13.62 | 14.59 |
| Weighted Avg Shares | 516.9M | 499.74M | 488.19M | 478.77M | 466.25M |
| Weighted Avg Shares (Diluted) | 521.88M | 504.04M | 492.29M | 482.09M | 468.7M |
Linde plc
NASDAQ:LIN
Intrinsic Alpha fair value
Locked
Current Price
$512.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.